Literature DB >> 194643

Cold agglutinins in infectious mononucleosis and heterophil-antibody-negative mononucleosis-like syndromes.

C A Horwitz, J Moulds, W Henle, G Henle, H Polesky, H H Balfour, B Schwartz, T Hoff.   

Abstract

Cold agglutinins (CA) were evaluated prospectively in patients with various mononucleosis syndromes and in a large control group. Cold agglutinins with anti-i specificity were seen mainly in heterophil-positive or -negative Epstein-Barr virus (EBV)-induced infectious mononucleosis (31.8% of cases). Unclassified CA with equal reactivity against cord and adult erythrocytes were seen in 56 of 150 (37.3%) cases of heterophil-antibody-positive infectious mononucleosis (IM), in 1 of 7 (14.3%) cases of heterophil-negative EBV-induced IM, and in 12 of 31 (38.7%) cases of the heterophil-negative mononucleosis-like syndrome due to cytomegalovirus or other unspecified agents. One patient with heterophil-positive IM had a persistent, partially papain sensitive CA with anti-Pr-like activity. Anti-i CA were seen in less than 1.0% of healthy young adults (500) or patients without mononucleosis (500) submitted for heterophil studies. Unclassified CA were noted in 3.2% of the latter 1000 samples.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194643

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Spurious macrocytosis in infectious mononucleosis.

Authors:  S E Gleeson; J A McSherry
Journal:  Can Med Assoc J       Date:  1983-12-15       Impact factor: 8.262

2.  Cold agglutinins of anti-Pr specificity in rubella embryopathy.

Authors:  A L König; H E Keller; R W Braun; D Roelcke
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

3.  Early Serologic Diagnosis of Mycoplasma pneumoniae Pneumonia: An Observational Study on Changes in Titers of Specific-IgM Antibodies and Cold Agglutinins.

Authors:  Sung-Churl Lee; You-Sook Youn; Jung-Woo Rhim; Jin-Han Kang; Kyung-Yil Lee
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

4.  Exacerbation of Secondary Cold Agglutinin Syndrome in the Setting of SARS-CoV-2.

Authors:  Yash V Bhagat; Siham Hussien; Helen Queenan; Miriam B Michael
Journal:  Cureus       Date:  2021-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.